Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Leukemia. 2017 Mar;31(3):734-738. doi: 10.1038/leu.2016.317. Epub 2016 Nov 2.

Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.

Author information

1
Internal Medicine III, Ulm University, Ulm, Germany.
2
Barts Cancer Institute, Queen Mary University of London, London, UK.
3
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
4
Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
5
Division of Hematology and Medical Oncology and The Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
6
New York Genome Center, New York, NY, USA.
7
Internal Medicine I, University of Cologne, Cologne, Germany.
8
Center for Clinical Research, Genomics Core Facility, Ulm University, Ulm, Germany.
9
Second Department of Medicine, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
10
Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA.
PMID:
27909343
PMCID:
PMC5332302
DOI:
10.1038/leu.2016.317
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center